An Australian biotechnology company that has expanded into the United States is soaring, recording revenue above $100 million in the first quarter as it works on cancer treatments.

Money Week with Scott Haywood π°πποΈ - 03 April 2026
40:10

Financial Literacy Month w/ Nicole Pedersen-McKinnon π°ππ
08:22

Money News with Scott Haywood π΅ππ» - Thursday, 2nd April
38:55